Summary

Biomedical researchers are beset by low morale and high uncertainty, along with funding swings that economists say make for an inefficient research enterprise. With a new landscape comes adaptation. As economists and others explore how biomedical research is shifting on a grand scale, Science set out to tell the stories of individuals. We examine how they are changing their science, their funding strategies, and their priorities—and why some are still enjoying success.